|
Introduction
of Amrinone
Amrinone (INN) or inamrinone, trade name InocorŪ, is a type 3
pyridine phosphodiesterase inhibitor. It is used in the
treatment of congestive heart failure.
Precautions of Amrinone
Amrinone may increase myocardial ischemia. Blood pressure,
pulse, and EKG should be constantly monitored. Amrinone should
only be diluted with normal saline or 1/2 normal saline; no
dextrose solutions should be used. Furosemide (Lasix) should
not be administered into an IV line delivering Amrinone.
Side Effects
of Amrinone
Reduction in platelets, nausea and vomiting cardiac
arrhythmias.
Disclaimer:
Information on this page is provided for general
information purposes. You should not make a clinical treatment
decision based on information contained in this page without
consulting other references including the package insert of
the drug, textbooks and where relevant, expert opinion. We
cannot be held responsible for any errors you make in
administering drugs mentioned on this page, nor for use of any
erroneous information contained on this page.
|
